Document is current
Any future updates will be listed below
-
Authors
Rauchmann, Boris-Stephan
Hamet, James
Lai, Jesyin
Kafi, Homeira
Rexwinkle, Joe
Brendel, Matthias
Franzmeier, Nicolai
Kurz, Carolin
Pogarell, Oliver
Levin, Johannes
Höglinger, Günter
Perneczky, Robert
-
Funding
Funding for this research was provided by:
Klinikum der Universität München
- License Information
-
More Information
Article History
Received: 21 August 2025
Accepted: 8 May 2026
First Online: 12 June 2026
Declarations
:
: The study was conducted following the Declaration of Helsinki. All participants provided written informed consent before inclusion. The protocol was approved by the ethics committee of LMU Munich (project numbers 17–755 and 17–569).
: All participants provided written consent for publication of de-identified study data. No personally identifiable information or images are included in this manuscript.
: R.P. has received honoraria for advisory boards and speaker engagements from Roche, EISAI, Eli Lilly, Biogen, Janssen-Cilag, AstraZeneca, Schwabe, Grifols, Novo Nordisk, and Tabuk. Vistim Labs, Inc. provided personnel for this research on EEG-based diagnostics for dementia. The results have potential commercial implications for Vistim Labs. M.B. is a member of the Neuroimaging Committee of the EANM. M.B. has received speaker honoraria from Roche, GE Healthcare, Iba, and Life Molecular Imaging; has advised Life Molecular Imaging and GE Healthcare; and is currently on the advisory board of MIAC. N.F. has received honoraria for consulting and speaker engagements from GE Healthcare, Life Molecular Imaging, EISAI, Biogen, and MSD.
